AstraZeneca Boosts Heart, Kidney Business With $1.8 Billion

AstraZeneca said on Monday it had struck a deal to buy U.S.-based drug developer CinCor Pharma Inc for up to $1.8 billion to increase its stock of heart and kidney drugs.

Related Keywords

Sweden , France , French , Eli Lilly Jardiance , Astrazeneca , Boehringer Ingelheim , Novo Nordisk , Cincor Pharma Inc , Eli Lilly , Mene Pangalos , Nasdaq Biotechnology Index , Corvidia Therapeutics , Business , ,